Entity Common Stock, Shares Outstanding of Vyant Bio, Inc. from 08 May 2013 to 15 Mar 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vyant Bio, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 May 2013 to 15 Mar 2023.
  • Vyant Bio, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 15 Mar 2023 was 6,267,708, a 78% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Vyant Bio, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 6,267,708 -22,730,461 -78% 15 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 5,910,308 -23,079,315 -80% 10 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q1 2022 28,998,169 +17,990,983 +163% 15 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 28,989,623 +24,914,730 +611% 09 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 28,985,814 +26,724,931 +1182% 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 11,007,186 26 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 4,074,893 -56,333,574 -93% 09 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 2,260,883 19 Jun 2020 10-Q 24 Jun 2020 2020 Q1
Q4 2019 2,099,789 18 Nov 2019 10-Q 19 Nov 2019 2019 Q3
Q3 2019 60,408,467 +32,661,970 +118% 16 Aug 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 56,276,222 +28,527,725 +103% 27 Mar 2019 10-K 16 Apr 2019 2018 FY
Q3 2018 27,746,497 +3,492,666 +14% 13 Nov 2018 10-Q 19 Nov 2018 2018 Q3
Q2 2018 27,746,497 +7,956,481 +40% 06 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 27,748,497 +8,812,903 +47% 21 Mar 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 24,253,831 +5,366,237 +28% 06 Nov 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 19,790,016 +3,669,922 +23% 09 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 18,935,594 +5,283,320 +39% 01 Mar 2017 10-K 23 Mar 2017 2016 FY
Q3 2016 18,887,594 +8,235,670 +77% 01 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 16,120,094 +6,269,934 +64% 01 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 13,652,274 +3,831,105 +39% 01 Mar 2016 10-K 10 Mar 2016 2015 FY
Q3 2015 10,651,924 +928,255 +9.5% 01 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 9,850,160 +153,502 +1.6% 01 Aug 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 9,821,169 +545,583 +5.9% 01 Mar 2015 10-K 16 Mar 2015 2014 FY
Q3 2014 9,723,669 +458,285 +4.9% 01 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 9,696,658 +5,352,039 +123% 01 Aug 2014 10-Q/A 23 Sep 2014 2014 Q2
Q1 2014 9,275,586 +4,958,895 +115% 17 Mar 2014 10-K 28 Mar 2014 2013 FY
Q3 2013 9,265,384 01 Nov 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 4,344,619 05 Aug 2013 10-Q 05 Aug 2013 2013 Q2
Q1 2013 4,316,691 08 May 2013 10-Q/A 04 Jun 2013 2013 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.